Crossmark

Optimizing therapeutic drug monitoring of mirtazapine — applying therapeutic reference range, concentration–dose ratio/dose-related concentration, and metabolic ratio in a naturalistic setting

Crossref DOI link: https://doi.org/10.1007/s00228-025-03907-6

Published Online: 2025-08-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nierychlewski, Kajetan

Paal, Michael

Meinzer, Sebastian

Musil, Richard

Schwarz, Markus
Funding

Funding for this research was provided by:

Klinikum der Universität München
License Information

Text and Data Mining valid from 2025-08-20

Version of Record valid from 2025-08-20
More Information

Article History

Received: 22 April 2025

Accepted: 11 August 2025

First Online: 20 August 2025

Declarations

:

: The study was approved by the Ethics Committee of the University of Munich (project number 365–15, date: 12.08.2015) and conducted in accordance with the Declaration of Helsinki.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below